Clinical Trial Update: rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated recombinant human thyroid-stimulating hormone (rhTSH) to influence thyroid size and optimize radioiodine therapy in benign goiter, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Goiter
• Graves Disease

Drugs mentioned

• Thyrogen (thyrotropin alfa)

Snippet

Sponsor: Odense University Hospital | Conditions: Benign Nontoxic and Toxic Goiter, Graves' Disease | Phase 2 | Status: COMPLETED